Search Results for: infliximab

February 23, 2015February 24, 2015

Infliximab in Severe Ulcerative Colitis Delays and Prevents Early Colectomy

News, Ulcerative colitis

According to a study published in the journal Clinical Gastroenterology and Hepatology, the use of infliximab in patients with acute severe ulcerative colitis reduces the need for early colectomy. In the study ... Read more

December 5, 2014September 28, 2016

First Biosimilar Of Infliximab Drug In India Was Launched By Ranbaxy Laboratories Ltd

News

Infimab, the first Remicade (Infliximab) biosimilar revealed to be successful in treating inflammatory diseases such as rheumatoid arthritis, ankylosing spondylitis, Crohn’s Disease, ulcerative colitis, psoriasis and psoriatic arthritis, was recently launched ... Read more

December 3, 2014September 28, 2016

IBD Therapy Infliximab Tested in Pediatric Patients 7 and Under

IBD News, News

A recent study entitled “Infliximab therapy in pediatric patients 7 years of age and younger” reports that infliximab therapy is less efficient in treating inflammatory bowel disease in children aged ... Read more

November 3, 2014September 28, 2016

Celltrion Healthcare Presents Clinical Data Showing That Inflammatory Bowel Disease Patients Should Be Treated With Biosimilar Monoclonal Antibody (mAb) Infliximab

IBD News, News

Documented clinical experience was recently presented by Celltrion Healthcare’s satellite symposium during the 2014 United European Gastroenterology (UEGW) showing evidence that patients with inflammatory bowel disease (IBD) — Crohn’s disease and ulcerative colitis — should be treated with the biosimilar monoclonal antibody (mAb) infliximab. ... Read more

September 15, 2014September 15, 2014

Infliximab Maintains IBD Remission Longer with Dose Adjustment and Monitoring

IBD News, News

It is estimated that roughly 1.4 million Americans suffer from inflammatory bowel diseases (IBDs) such as Crohn’s disease and ulcerative colitis. Every year, over 30,000 new IBD diagnoses are made, ... Read more

September 11, 2014September 11, 2014

Restarting Infliximab Effective After Other Failed IBD Treatments

IBD News, News

Synthetic antibody formulation infliximab may be an effective component of a drug regimen for patients with inflammatory bowel disease (IBD) such as Crohn’s disease and ulcerative colitis. While a number ... Read more

February 25, 2021February 23, 2021

Surviving Texas’ ‘SNOVID-21’ With Crohn’s and Other Medical Needs

Columns, Intestinal Fortitude - a Column by Emmeline Olson

After the toilet paper and hand sanitizer hoarding of 2020, I thought I was equipped for anything. By luck and God’s grace, I survived the winter storm disaster in Texas, ... Read more

February 18, 2021February 16, 2021

Venturing Back Into the COVID-19 World After a Year of Self-quarantine

Columns, Intestinal Fortitude - a Column by Emmeline Olson

After my second dose of the Moderna COVID-19 vaccine last Friday, I expected days of flu-like symptoms. Luckily, I only had a low-grade fever the next day and fatigue for ... Read more

January 28, 2021January 25, 2021

My COVID-19 Vaccine Experience, Part 2: One Down, One to Go

Columns, Intestinal Fortitude - a Column by Emmeline Olson

Last in a series. Read part one. In last week’s column, my hope of getting a COVID-19 vaccine was slowly chipped away while I navigated the difficult process. Almost two ... Read more

January 7, 2021January 5, 2021

Finding a Remedy When Remicade Stops Working

Columns, Intestinal Fortitude - a Column by Emmeline Olson

Since September, I’ve been getting Remicade (infliximab) infusions every four weeks. My gastroenterologist changed my schedule from every eight weeks after my colonoscopy in August showed I was no longer ... Read more